• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 VACCESS CT POWER-INJECTABLE IMPLANTABLE PORT, CHRONOFLEX, 6F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 VACCESS CT POWER-INJECTABLE IMPLANTABLE PORT, CHRONOFLEX, 6F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 7480000
Device Problem Migration (4003)
Patient Problems Pain (1994); Embolism/Embolus (4438); Thrombosis/Thrombus (4440); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 01/03/2021
Event Type  Injury  
Manufacturer Narrative
H10: as the lot number for the device was not provided, a review of the device history records could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through the litigation process that sometime post a port placement, the catheter had allegedly migrated.It was further reported that the patient was allegedly diagnosed with thrombosis and internal jugular vein thromboembolism.The current status of the patient is unknown.
 
Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not requested as the lot number reported is unknown.Investigation summary: the device was not returned for evaluation.Medical records were provided.The medical record states that for the treatment of chemotherapy infusion to bladder cancer an right sided port-a-cath was placed.Approximately a month later, the patient had a complaint of neck pain which occurred during in the bit turning the patient felt something pop in the neck region and further the pain was occurred.And computer tomography angiogram was performed off neck shows the right put a catheter tip it's standard up the right internal jugular vein and the tip lies at the level of c3 vertebral body.The study also shows the evidence of thrombosis at the right internal jugular vein extending from the distal tape cranially up to the level of c2, and expansion of opacified proximal right internal jugular vein with stranding adjacent to the thrombosis segment and the opacified segment of the distal internal jugular vein the portion of a bad suicide and enlargement of right internal jugular was also being partially thrombosed.On the same day, an another computer tomography angiogram was performed which showed no pulmonary embolism and the right internal jugular vein thrombosis at the tip of migrated chest port catheter was able to be observed.The patient had also had an acute right internal jugular vein thrombosis at the site of port-a-catheter with the catheter tip that has been migrated up into the internal jugular vein.Hence, the migrated port-a-cath need to be removed.On the next day, x-ray of chest showed the patient's right sided port-a-cath now lies in internal jugular vein, further, the patient underwent cystoscopy and the right retrograde pyelogram and stent placement procedure and at the same day the port was also being removed.As submitted medical record show us the evidence of migrated catheter tip, the investigation is confirmed for they reported migration.Additionally, it can be confirmed that the patient experienced thrombosis, embolism, and pain.However, the relationship to the port is unknown.Furthermore, the clinical condition alleged in the complaint cannot be confirmed.Based upon available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported through the litigation process that one week and six days post a port placement, the tip of the catheter had allegedly migrated up into the internal jugular vein.It was further reported that the patient allegedly experienced neck pain and was diagnosed with thrombosis and internal jugular vein thromboembolism.Reportedly, the port was removed.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VACCESS CT POWER-INJECTABLE IMPLANTABLE PORT, CHRONOFLEX, 6F
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key18693775
MDR Text Key335187025
Report Number3006260740-2024-00487
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741027475
UDI-Public(01)00801741027475
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K063377
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 03/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number7480000
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/18/2024
Initial Date FDA Received02/13/2024
Supplement Dates Manufacturer Received03/27/2024
Supplement Dates FDA Received04/12/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age49 YR
Patient SexFemale
-
-